U.S. Lawmakers Seek to Empower HHS to Destroy Counterfeit Chinese Tobacco Products

Nov.11.2025

Bipartisan members of the U.S. Congress have introduced the “Ensuring the Necessary Destruction of Illicit Chinese Tobacco Act” (END Act), seeking to amend the Federal Food, Drug, and Cosmetic Act to authorize the Department of Health and Human Services (HHS) to directly destroy adulterated, misbranded, or counterfeit imported tobacco products.Major tobacco companies, including Altria, along with several public health organizations, have announced their support for the bill.

Key Points

Three members of Congress jointly introduced the Ensuring the Necessary Destruction of Illicit Chinese Tobacco Act, aiming to crack down on the importation of illicit and counterfeit tobacco products.
The bill would amend Section 381(a) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 381(a)), granting the HHS Secretary explicit authority to destroy adulterated, misbranded, or counterfeit imported tobacco products
The new rule is intended to close regulatory loopholes, prevent illegal e-cigarettes and tobacco products from entering the U.S. market, and strengthen federal agencies’ powers to act at the import stage.
The legislation has received backing from 7-Eleven, Altria, the Campaign for Tobacco-Free Kids (CTFK), the American Heart Association, the American Lung Association, the National Association of Convenience Stores (NACS), NATSO (Representing America’s Travel Centers and Truck Stops), and SIGMA (America’s Leading Fuel Marketers).

2Firsts,November 11, 2025 — According to the U.S. House of Representatives, multiple lawmakers have introduced the Ensuring the Necessary Destruction of Illicit Chinese Tobacco Act to strengthen enforcement tools, block the import of illicit tobacco products, and protect American consumers from unsafe and counterfeit goods.

The sponsors include Congresswoman Beth Van Duyne (R-TX-24), Senator John Cornyn (R-TX), and Congresswoman Debbie Dingell (D-MI-6).

The legislation seeks to amend Section 381(a) of the Federal Food, Drug, and Cosmetic Act, explicitly authorizing the Secretary of Health and Human Services to destroy imported tobacco products determined to be adulterated, misbranded, or counterfeit.

This amendment would formally place tobacco products under the same regulatory framework as counterfeit drugs and medical devices, ensuring that such products can be directly disposed of when intercepted by federal authorities.

The bill has already gained broad institutional support from 7-Eleven, Altria, Campaign for Tobacco-Free Kids, the American Heart Association, the American Lung Association, NACS, NATSO, and SIGMA.

Congresswoman Van Duyne stated:

“We have seen too many illegal vapes slipping through the enforcement cracks, posing health and safety risks to Americans”

Source: Image: House.gov

References:

[1] Rep. Van Duyne and Senator Cornyn Introduce the END Act to Crack Down on Illegal Vape Imports

[2] Ensuring the Necessary Destruction of Illicit Chinese Tobacco Act

Also Read:

[1] US Congressman Launched Inquiry into Illegal Vapes Imports, Sent Letters to 5 Chinese Manufacturers and 6 US Distributors and Wholesalers

[2] Proposed Bill to Abolish ATF by US Representatives Boebert and Burlison

[3] Oversight Committee Hearing on FDA Regulations and Crises Management

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn

Notice

1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

Copyright

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

AI Assistance Disclaimer

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com